Clinical Trial Update: Dexmedetomidine in Reducing Postoperative Delirium in Cardiac Surgery Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating whether dexmedetomidine reduces postoperative delirium in patients undergoing cardiac surgery is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Delirium
• Sleep Disorders

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Xijing Hospital | Conditions: Postoperative Delirium, Preoperative Sleep Disorder | Phase 3 | Status: RECRUITING